Foamix Pharmaceuticals Ltd. Selling, General and Administrative Expense
Foamix Pharmaceuticals Ltd. reported Selling, General and Administrative Expense of $45.11 million for the 12-month period ending 2019-12-31, per its 10-K filed 2020-03-12.
Discontinued › Expense Statement › Operating Expenses
us-gaap:SellingGeneralAndAdministrativeExpense · last filed 2020-03-12
- Foamix Pharmaceuticals Ltd. selling, general and administrative expense for the quarter ending 2019-12-31 was $22.22M, a 456.33% increase year-over-year.
- Foamix Pharmaceuticals Ltd. selling, general and administrative expense for the quarter ending 2019-09-30 was $10.75M, a 224.78% increase year-over-year.
- Foamix Pharmaceuticals Ltd. selling, general and administrative expense for the quarter ending 2019-06-30 was $6.80M, a 133.86% increase year-over-year.
- Foamix Pharmaceuticals Ltd. selling, general and administrative expense for the quarter ending 2019-03-31 was $5.34M, a 40.59% increase year-over-year.
- Foamix Pharmaceuticals Ltd. selling, general and administrative expense for fiscal 2019 was $45.11M, a 221.94% increase from fiscal 2018.
- Foamix Pharmaceuticals Ltd. selling, general and administrative expense for fiscal 2018 was $14.01M, a 21.95% increase from fiscal 2017.
- Foamix Pharmaceuticals Ltd. selling, general and administrative expense for fiscal 2017 was $11.49M, a 24.62% increase from fiscal 2016.
- Foamix Pharmaceuticals Ltd. selling, general and administrative expense for fiscal 2016 was $9.22M, a 31.19% increase from fiscal 2015.
| Period end | Selling, General and Administrative Expense 3 month | Selling, General and Administrative Expense 6 month | Selling, General and Administrative Expense 9 month | Selling, General and Administrative Expense 12 month |
|---|---|---|---|---|
| 2019-12-31 | $22.22M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-12 | $32.97M derived: sum of 2 quarters · filed 2020-03-12 | $39.77M derived: sum of 3 quarters · filed 2020-03-12 | $45.11M 10-K · filed 2020-03-12 |
| 2019-09-30 | $10.75M 10-Q · filed 2019-11-12 | $17.55M derived: sum of 2 quarters · filed 2019-11-12 | $22.89M 10-Q · filed 2019-11-12 | $26.89M derived: sum of 4 quarters · filed 2020-03-12 |
| 2019-06-30 | $6.80M 10-Q · filed 2019-08-07 | $12.15M 10-Q · filed 2019-08-07 | $16.14M derived: sum of 3 quarters · filed 2020-03-12 | $19.45M derived: sum of 4 quarters · filed 2020-03-12 |
| 2019-03-31 | $5.34M 10-Q · filed 2019-05-07 | $9.34M derived: sum of 2 quarters · filed 2020-03-12 | $12.65M derived: sum of 3 quarters · filed 2020-03-12 | $15.56M derived: sum of 4 quarters · filed 2020-03-12 |
| 2018-12-31 | $3.99M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-12 | $7.30M derived: sum of 2 quarters · filed 2020-03-12 | $10.21M derived: sum of 3 quarters · filed 2020-03-12 | $14.01M 10-K · filed 2020-03-12 |
| 2018-09-30 | $3.31M 10-Q · filed 2019-11-12 | $6.22M derived: sum of 2 quarters · filed 2019-11-12 | $10.02M 10-Q · filed 2019-11-12 | $12.30M derived: sum of 4 quarters · filed 2020-03-12 |
| 2018-06-30 | $2.91M 10-Q · filed 2019-08-07 | $6.71M 10-Q · filed 2019-08-07 | $8.99M derived: sum of 3 quarters · filed 2020-03-12 | $11.93M derived: sum of 4 quarters · filed 2020-03-12 |
| 2018-03-31 | $3.80M 10-Q · filed 2019-05-07 | $6.09M derived: sum of 2 quarters · filed 2020-03-12 | $9.02M derived: sum of 3 quarters · filed 2020-03-12 | $12.47M derived: sum of 4 quarters · filed 2020-03-12 |
| 2017-12-31 | $2.29M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-12 | $5.22M derived: sum of 2 quarters · filed 2020-03-12 | $8.67M derived: sum of 3 quarters · filed 2020-03-12 | $11.49M 10-K · filed 2020-03-12 |
| 2017-09-30 | $2.93M 10-Q · filed 2018-11-07 | $6.38M derived: sum of 2 quarters · filed 2018-11-07 | $9.21M 10-Q · filed 2018-11-07 | |
| 2017-06-30 | $3.45M 10-Q · filed 2018-08-08 | $6.27M 10-Q · filed 2018-08-08 | ||
| 2017-03-31 | $2.82M 10-Q · filed 2018-05-08 | |||
| 2016-12-31 | $9.22M 10-K · filed 2019-02-28 | |||
| 2016-06-30 | $2.13M 6-K · filed 2017-08-08 | $3.84M 6-K · filed 2017-08-08 | ||
| 2015-12-31 | $7.03M 10-K · filed 2018-03-01 | |||
| 2015-06-30 | $2.02M 6-K · filed 2016-08-10 | $3.40M 6-K · filed 2016-08-10 | ||
| 2014-12-31 | $2.96M 20-F · filed 2017-02-21 | |||
| 2014-06-30 | $409.00K 6-K · filed 2015-10-19 | $867.00K 6-K · filed 2015-10-19 | ||
| 2013-12-31 | $1.22M 20-F · filed 2016-03-02 | |||
| 2012-12-31 | $953.00K 20-F · filed 2015-03-17 |